| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/26/2009 | EP1501804B1 Isoquinoline derivatives mao-b inhibitors |
| 08/26/2009 | EP1496929A4 Use of c5a receptor antagonist in the treatment of fibrosis |
| 08/26/2009 | EP1485087B1 (+)-2- [1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione for use in treating psoriasis by oral administration |
| 08/26/2009 | EP1478328A4 Bioactive keratin peptides |
| 08/26/2009 | EP1462442B1 Crystals of bicalutamide and process for their production |
| 08/26/2009 | EP1389096B9 Delivery of opioids through an inhalation route |
| 08/26/2009 | EP1296714B1 Combination of CpG and antibodies directed against CD19,CD20, CD22 or CD40 for the treatment or prevention of cancer. |
| 08/26/2009 | EP1282636B1 Trp8, a transient receptor potential channel expressed in taste receptor cells |
| 08/26/2009 | EP1218375B1 Pharmaceutically active sulfonyl amino acid derivatives |
| 08/26/2009 | EP1173441B1 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations |
| 08/26/2009 | EP1061812B1 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 08/26/2009 | CN101516400A Therapeutic agent for acceleration of spinal nerve repair comprising ghrelin, derivative thereof or substance capable of acting on GHS-R1a as active ingredient |
| 08/26/2009 | CN101516399A Therapeutic agent for acceleration of spinal nerve repair comprising desacyl ghrelin or derivative thereof as active ingredient |
| 08/26/2009 | CN101516329A Cell activator, collagen production promoter, collagenase activity inhibitor, melanin formation inhibitor, antioxidant agent, antiinflammatory agent, fat accumilation inhibitor, external preparation f |
| 08/26/2009 | CN101514354A Sea cucumber polypeptide, preparation method and application thereof |
| 08/26/2009 | CN101514192A Quinoxalinone derivative with activity for reversing tumor cell multidrug resistance and preparation method thereof |
| 08/26/2009 | CN101513402A Antiviral agent |
| 08/26/2009 | CN100532559C Virus envelope vector for gene transfer |
| 08/26/2009 | CN100532545C A method for producing recombinant viruses using site-specific recombination |
| 08/26/2009 | CN100531796C FGFR agonists |
| 08/26/2009 | CN100531731C Use of glutamate, glutamate derivatives or metabolites, glutamate analogues or mixtures thereof for the preparation of composition for the treatment of osteoporosis |
| 08/26/2009 | CN100531728C Use of neuron sodium ion pass antagonist for controlling homothermal animal ectoparasite |
| 08/25/2009 | US7579467 N-phenyl-2-pyrimidine-amine derivatives |
| 08/25/2009 | US7579439 Modulation of IL-2- and IL-15-mediated T cell responses |
| 08/25/2009 | US7579432 Cyclic peptides as G-protein-coupled receptor antagonists |
| 08/25/2009 | US7579379 bis-[2-(pivaloylamino)phenyl]disulfide; cholesteryl ester transfer protein (CETP); atherosclerosis, hyperlipidemia |
| 08/25/2009 | US7579367 Aryl substituted pyridines and the use thereof |
| 08/25/2009 | US7579366 Epothilone derivatives and their synthesis and use |
| 08/25/2009 | US7579362 3-(6-p-Tolyl-pyridin-3-yloxy)-1-aza-bicyclo[2.2.2]octane; treatment of psychotic disorders such as schizophrenia, mania, depression and anxiety; neurodegenerataive disorders such as senile dementia, Alzhelmer's disease and other intellectual impairment disorders |
| 08/25/2009 | US7579358 Scopine 2,2-diphenylpropionate-metho halides and other salts: propellant-free solution with ethanol and water and an acid; optimum nebulization; storage stability; nebulizer |
| 08/25/2009 | US7579357 Antidiabetic agents; obesity; controlling appetite |
| 08/25/2009 | US7579352 Retinoic acid mimetic anilides |
| 08/25/2009 | US7579347 Vanilloid receptor ligands and their use in treatments |
| 08/25/2009 | US7579342 Pteridine compounds for the treatment of psoriasis |
| 08/25/2009 | US7579327 Isolated polynucleotide sequences; controlling neovasculization; cell growth regulators |
| 08/25/2009 | US7579315 Casein peptides for alleviating or preventing aging of skin |
| 08/25/2009 | US7579186 Human monoclonal antibody against TGF-β type II receptor and medicinal use thereof |
| 08/25/2009 | US7579166 lysosomal enzyme having a mannose-6-phosphate-containing acidic sugar chain; a labeling marker for transporting into lysosomes; used as a drug effective in treatment of human lysosomal enzyme deficiencies |
| 08/25/2009 | US7579023 Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals |
| 08/25/2009 | US7579001 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| 08/25/2009 | CA2538072C Amide-type carboxamide derivatives |
| 08/25/2009 | CA2439078C Composition improving age-related physiological deficits and increasing longevity |
| 08/25/2009 | CA2414967C Valproic acid and derivatives thereof as histone deacetylase inhibitors |
| 08/25/2009 | CA2382521C Oligonucleotide n3'.fwdarw.p5' thiophosphoramidates: their synthesis and use |
| 08/25/2009 | CA2375671C 4-phenyl-pyrimidine derivatives |
| 08/25/2009 | CA2366932C Cyclic protein tyrosine kinase inhibitors |
| 08/25/2009 | CA2269246C Substituted tricyclics |
| 08/25/2009 | CA2234500C Novel biologically active silicon-based compositions |
| 08/25/2009 | CA2099541C Cyclic adhesion inhibitors |
| 08/20/2009 | WO2009102894A2 Arginine-conjugated bioreducible poly (disulfide amine) polymers for gene delivery systems |
| 08/20/2009 | WO2009102021A1 Treatment of retinal disease by activation of the function of bone marrow-derived stem cell or progenitor cell thereof |
| 08/20/2009 | WO2009101968A1 Anti-adam-15 antibodies and utilization of the same |
| 08/20/2009 | WO2009101956A1 Novel substance fki-3864 and method for production thereof |
| 08/20/2009 | WO2009101917A1 Bicycloamine derivative |
| 08/20/2009 | WO2009101812A1 Glutamic acid transporter inhibitor |
| 08/20/2009 | WO2009101700A1 Bioassay method for yokkansan |
| 08/20/2009 | WO2009101684A1 Drug for preventing and/or treating visceral fusion |
| 08/20/2009 | WO2009100890A1 Products made of o-acylated hydroxycarboxylic acids and amino acids, the production, biological activities, cosmetically or pharmaceutically effective compositions and use thereof, particularly as food additives, and as cosmetic additives |
| 08/20/2009 | US20090210954 Genes |
| 08/20/2009 | US20090209734 Peptidyl prodrugs and linkers and stabilizers useful therefor |
| 08/20/2009 | US20090209643 Method for modulating stem cell growth |
| 08/20/2009 | US20090209616 Preparation of romidepsin |
| 08/20/2009 | US20090209563 Pyridinoylpiperidines as 5-HT1F agonists |
| 08/20/2009 | US20090209562 Fused ring 4-oxopyrimidine derivative |
| 08/20/2009 | US20090209548 Formulation for stimulating hair growth |
| 08/20/2009 | US20090209495 Use of edg receptor binding agents in cancer |
| 08/20/2009 | US20090209487 Compositions of carbohydrates as dietary supplements |
| 08/20/2009 | US20090209479 Thiocarbon-protecting groups for rna synthesis |
| 08/20/2009 | US20090209461 Modification of feeding behavior |
| 08/20/2009 | US20090209037 Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 08/20/2009 | US20090209034 Tumour rejection antigens |
| 08/20/2009 | US20090208972 Cytotoxic protein and utlization thereof |
| 08/20/2009 | US20090208568 Gellan Seamless Breakable Capsule and Process for Manufacturing Thereof |
| 08/20/2009 | US20090208559 Device for delivering active ingredients to humans, animals and plants |
| 08/20/2009 | US20090208551 Biological implantation material and method for preparing same |
| 08/20/2009 | US20090208504 Polypeptides involved in immune response |
| 08/20/2009 | US20090208486 Pharmaceutical composition comprising cxcr3 inhibitor |
| 08/20/2009 | US20090208474 Biological entities and the use thereof |
| 08/20/2009 | US20090208415 Tropane compounds |
| 08/20/2009 | US20090208409 Encapsulated nanoparticles for computed tomography imaging |
| 08/20/2009 | DE102008009800A1 Verfahren zur vorbeugenden Behandlung von Gesundheitsstörungen bei kalbenden Kühen Method for the prophylactic treatment of ill health at calving cows |
| 08/20/2009 | CA2714657A1 Anti-adam-15 antibodies and utilization of the same |
| 08/20/2009 | CA2714591A1 Bicycloamine derivative |
| 08/20/2009 | CA2713288A1 Compounds with mdr1-inverse activity |
| 08/19/2009 | EP2090657A2 Anti-IL-12 antibodies, compositions, methods and uses |
| 08/19/2009 | EP2090656A1 Mutant androgen receptor, cancer cells expressing the same, method of constructing the same and use thereof |
| 08/19/2009 | EP2090654A1 PARTIAL FRAGMENT OF REIC/Dkk-3 GENE AND THERAPEUTIC AGENT FOR CANCER CONTAINING THE SAME |
| 08/19/2009 | EP2090571A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation |
| 08/19/2009 | EP2090312A1 (S,S) reboxetine for treating attention deficit disorder |
| 08/19/2009 | EP2090309A1 Use of thiazole inhibitors of fatty acid oxidation of formula (I) for the treatment of Alzheimer's disease and other neurological conditions |
| 08/19/2009 | EP2090304A2 Use of sugar phosphates, sugar phosphate analogues, amino acids and/or amino acid analogues for modulating the glycose-enzyme complex, the malate aspartate shuttle and/or transaminases |
| 08/19/2009 | EP2090177A1 Food products having enhanced cocoa polyphenol content |
| 08/19/2009 | EP2089026A2 Inhibitors of protein tyrosine phosphatase for the promotion of physiological cardiac hypertrophy |
| 08/19/2009 | EP2089023A2 Methods of treating neuropathic pain with agonists of ppar-gamma |
| 08/19/2009 | EP2089018A2 Methods of treating cognitive impairment and dementia |
| 08/19/2009 | EP2089017A2 Methods of treating neuropathic pain by modulation of glycogenolysis or glycolysis pathways |
| 08/19/2009 | EP1915144A4 Method to reduce oxidative damage and improve mitochondrial efficiency |
| 08/19/2009 | EP1482973B1 Methods of modulating cd200 receptors |
| 08/19/2009 | EP1463498B1 pharmaceutical COMPOSITION comprising a catechin, ascorbic acid, proline and lysine FOR THE TREATMENT OF NEOPLASTIC DISEASES |
| 08/19/2009 | EP1414466B1 Combinations for the treatment of inflammatory disorders |